LEAP Consulting Launches Practice to Aid Labs in FDA LDT Compliance
LEAP Consulting Group, a specialized digital consultancy for the clinical laboratory sector, is thrilled to introduce a new service designed to assist CLIA-certified labs in navigating the FDA’s updated requirements…
Ontrak Health Previews Q2 2024 Financial Results
Ontrak, Inc. (NASDAQ: OTRK), a leader in AI-powered and technology-driven behavioral healthcare, today released its expected financial results for the second quarter ending June 30, 2024. These results are pending…
AN2 Therapeutics Updates on EBO-301 Study of Epetraborole for MAC Lung Disease
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company specializing in novel small molecule therapies from its boron chemistry platform, today announced topline results from the Phase 2 portion of the…
Phonak Unveils Infinio Portfolio with AI-Driven Speech Clarity in Audéo Sphere
Phonak, a Sonova brand, is excited to introduce the new Infinio hearing aid portfolio, featuring the groundbreaking Audéo Sphere Infinio. This hearing aid is the world’s first to use a…
Hims & Hers Reports Q2 2024 Financials
Hims & Hers Health, Inc. (NYSE: HIMS), a leading health and wellness platform, has released its financial results for the second quarter ended June 30, 2024. The details are available…
Concentric Analgesics Reports Two Weeks of Pain Relief and Early Opioid Cessation in Surgical Procedures
Concentric Analgesics, Inc., a clinical-stage biopharmaceutical firm specializing in innovative non-opioid pain treatments, has unveiled new positive clinical data for vocacapsaicin, its leading product candidate for managing postsurgical pain. The…
Enanta Pharmaceuticals Reports Q3 Fiscal Results
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotech firm focused on developing small molecule drugs for virology and immunology, has reported its financial results for the fiscal third quarter ending June…
Delcath Systems Reports Q2 2024 Results and Key Updates
Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company specializing in treating primary and metastatic liver cancers, has announced its financial results and business highlights for the second quarter ended…
CUSM Gets Bank of America Grant to Improve Rural Healthcare Access
California University of Science and Medicine (CUSM) has announced a grant from Bank of America to enhance healthcare in rural Inland Empire communities. The funding will support CUSM’s initiative to…
Tris Pharma Reveals Strong Safety and Efficacy Data for Cebranopadol, a New Pain Therapy
Tris Pharma, Inc., a biopharmaceutical company specializing in ADHD, pain, addiction, and neurological disorders, has announced new clinical data showcasing that cebranopadol, a dual nociceptin/orphanin FQ peptide (NOP) receptor and…
Advanced Sterilization Products and PENTAX Medical Gain FDA Clearance for New Duodenoscope Sterilization Cycle
Advanced Sterilization Products (ASP), a division of Fortive (NYSE: FTV), and PENTAX Medical, a division of HOYA, are excited to announce FDA clearance for the new ULTRA GI™ Cycle. This…
Eyedaptic Launches EYE6 with Ivy: AI-Powered Visual Assistant for Macular Degeneration
Eyedaptic, a leader in vision-enhancement technology, has introduced the EYE6 with Ivy, an advanced wearable vision aid featuring an AI-powered visual assistant. This next-generation smart glasses product is designed to…